Related references
Note: Only part of the references are listed.The relationship between progression-free and post-progression survival in treating four types of metastatic cancer
Russell J. Bowater et al.
CANCER LETTERS (2008)
Disease progression as a predictor of overall survival in metastatic breast cancer: a meta-analysis
B. Sherrill et al.
EJC SUPPLEMENTS (2008)
Prediction of survival benefits from progression-free survival in patients with advanced non small cell lung cancer: Evidence from a pooled analysis of 2,838 patients randomized in 7 trials
M. E. Buyse et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Evaluation of tumor response, disease control, progression-free survival, and time to progression as potential surrogate end points in metastatic breast cancer
Tomasz Burzykowski et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Exploring and validating surrogate endpoints in colorectal cancer
Tomasz Burzykowski et al.
LIFETIME DATA ANALYSIS (2008)
Trouble at the office
Malorye Allison
NATURE BIOTECHNOLOGY (2008)
Use of progression-free survival as a surrogate marker in oncology trials: some regulatory issues
Aloka Chakravarty et al.
STATISTICAL METHODS IN MEDICAL RESEARCH (2008)
Progression-free survival is a surrogate for survival in advanced colorectal cancer
Marc Buyse et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Surrogate end points for median overall survival in metastatic colorectal cancer: Literature-based analysis from 39 Randomized controlled trials of first-line chemotherapy
Patricia A. Tang et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Surrogate markers and survival in women receiving first-line combination anthracycline chemotherapy for advanced breast cancer
A Hackshaw et al.
BRITISH JOURNAL OF CANCER (2005)
Share Paper
